TABLE 1.
Candidate | Sample type
|
Species | Method of detection | Radiation dose (collection time point postirradiation) | |||
---|---|---|---|---|---|---|---|
TBI plasmaa | Cell lineb | PBL ex vivoc | Blood ex vivod | ||||
ADAM9 | ≈ | − | − | ≈ | Human | Western blot | PBL (7 Gy, 1 h) |
Cell (0.5–4 Gy, 6–48 h) | |||||||
ALBUMIN | − | ≈ | ≈ | − | Human/mouse | ELISA | Blood (2–4 Gy, 2–6 h) |
TBI plasma (1–8 Gy, 6–48 h) | |||||||
α-AMYLASE | − | − | ≈ | − | Mouse | ELISA | Cell (8 Gy, 24 h) |
Blood (8 Gy, 5 h) | |||||||
TBI plasma (1–8 Gy, 6–72 h) | |||||||
CUGBP1 | ≈ | − | ≈ | ≈ | Human | Western blot | Cell (2–7 Gy, 6–24 h) |
CUGBP2 | ≈ | − | ≈ | ≈ | Human | Western blot | Cell (2–7 Gy, 6 h) |
ENO1 | ≈ | ≈ | − | ≈ | Human | Western blot | PBL (7 Gy, 1 h) |
Cell (0.5–4 Gy, 1–6 h) | |||||||
FIBRINOGEN | + | ≈ | ≈ | − | Human/mouse | ELISA | Blood (8 Gy, 5 h) |
TBI plasma (1–8 Gy, 24 h–1 week) | |||||||
FMRP | ≈ | ≈ | − | ≈ | Human | Western blot | PBL (7 Gy, 1 h) |
γH2AX | ≈ | + | + | ≈ | Human/mouse | ELISA | PBL (2–8 Gy, 1–48 h) |
Cell (4 Gy, 1–24 h) | |||||||
IL1β | − | ≈ | ≈ | ≈ | Mouse | ELISA | e Partial-body irradiation (8 Gy, 24 h–1 week) |
MMP2 | − | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (1–8 Gy, 24–72 h) |
MMP3 | − | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (8 Gy, 24–72 h) |
MMP9 | + | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (1–8 Gy, 24–72 h) |
MUC1 | ≈ | − | − | ≈ | Human | Western blot | PBL (7 Gy, 1 h) |
Cell (2–12 Gy, 2–24 h) | |||||||
NSE | − | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (1–8 Gy, 24–72 h) |
S100B | − | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (8 Gy, 24–72 h) |
SAA | + | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (1–8 Gy, 6 h–3 weeks) |
ST3GAL1 | ≈ | − | − | − | Human | Western blot | PBL (2–8 Gy, 24–48 h) |
Cell (0.5–8 Gy, 1–48 h) | |||||||
Blood (2–8 Gy, 1–48 h) | |||||||
STFR | ≈ | ≈ | ≈ | − | Human | ELISA | Blood (2–4 Gy, 2–24 h) |
TRANSFERRIN | − | ≈ | ≈ | − | Human/mouse | ELISA | Blood (2–4 Gy, 2–24 h) |
TBI plasma (1–4 Gy, 24–72 h) | |||||||
VEGF | − | ≈ | ≈ | ≈ | Mouse | ELISA | TBI plasma (1–8 Gy, 24–72 h) |
Note. + = Antigen increase with irradiation; − = no response to irradiation; ≈ = not determined.
Plasma was harvested from TBI C57BL6 mice.
Cell lines of human origin were cultured and irradiated in vitro.
Human PBL were harvested, cultured and irradiated ex vivo.
Human blood was collected and irradiated ex vivo.
For this target C57BL6 mice were irradiated in a partial-body model to either head or trunk only.